These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1898534)

  • 21. [Metabolic disorders of branched-chain amino acids: most common forms of organic aciduria in the neonatal period].
    Sperl W; Lehnert W
    Klin Padiatr; 1990; 202(5):334-9. PubMed ID: 2214593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
    Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
    J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful repair and postoperative management of tetralogy of Fallot in a patient with maple syrup urine disease.
    Fukutomi M; Kitamura S; Kawachi K; Tsuji T; Hashimoto K; Yoshioka A
    Heart Vessels; 1993; 8(1):48-51. PubMed ID: 8454563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maple syrup urine disease in Thai infants.
    Pangkanon S; Charoensiriwatana W; Sangtawesin V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of dried blood spot monitoring of branched-chain amino acids for maple syrup urine disease: A retrospective chart review study.
    Kaur J; Nagy L; Wan B; Saleh H; Schulze A; Raiman J; Inbar-Feigenberg M
    Clin Chim Acta; 2020 Jan; 500():195-201. PubMed ID: 31678570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism.
    Thompson GN; Butt WW; Shann FA; Kirby DM; Henning RD; Howells DW; Osborne A
    J Pediatr; 1991 Jun; 118(6):879-84. PubMed ID: 2040923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration.
    Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK
    Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acrodermatitis enteropathica-like eruption during treatment of maple syrup urine disease: report of one case.
    Tain YL; Huang SC; Hung FC; Wang HS; Sun PC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):357-60. PubMed ID: 8942030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late-onset branched-chain ketoaciduria: (maple syrup urine disease).
    Morris MD; Fisher DA; Fiser R
    J Lancet; 1966 Mar; 86(3):149-52. PubMed ID: 5904649
    [No Abstract]   [Full Text] [Related]  

  • 32. [Maple syrup urine disease and cystathioninemia].
    Simma B; Sperl W; Berger H
    Padiatr Padol; 1989; 24(1):69-75. PubMed ID: 2497426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute encephalopathy due to late-onset maple syrup urine disease in a school boy].
    Qu SQ; Yang LC; Luan Z; Du K; Yang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):161-4. PubMed ID: 22433398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of Maple Syrup Urine Disease in Newborns.
    Harris-Haman P; Brown L; Massey S; Ramamoorthy S
    Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Simple and rapid determination of leucine by HPLC. Importance for extra-renal treatment of maple syrup urine disease].
    Garcia J; Galinier A; Periquet B; Broué P; Decramer S; Thouvenot JP; Caspar-Bauguil S
    Ann Biol Clin (Paris); 2002; 60(5):602-6. PubMed ID: 12368147
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biochemical studies in a patient with maple syrup urine disease (author's transl)].
    Vaca G; Rivas F; Sánchez-Corona J; Olivares N; Aguirre-Negrete MG; González-Quiroga G; Medina C; Hernández A; Cantú JM
    Rev Invest Clin; 1981; 33(4):379-82. PubMed ID: 7330511
    [No Abstract]   [Full Text] [Related]  

  • 38. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Branched chain ketoaciduria (maple syrup urine disease).
    Snyderman SE
    Clin Perinatol; 1976 Mar; 3(1):41-52. PubMed ID: 954344
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dietary treatment of maple syrup urine diseases].
    Guibaud P; de Parscau L; Guffon N; Laval MC
    Pediatrie; 1993; 48(10):681-6. PubMed ID: 8015866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.